Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference

Rhea-AI Summary

Bausch Health (NYSE:BHC) said Executive Vice President and CFO Jean-Jacques (JJ) Charhon and other management will attend the J.P. Morgan Global Leveraged Finance Conference in Miami Beach, Florida, from March 2–4, 2026 to meet with investors. This is a management investor engagement announcement.

Market Context

This announcement highlights Bausch Health’s plan for senior management, including its CFO, to engag...

Analysis

This announcement highlights Bausch Health’s plan for senior management, including its CFO, to engage investors at a major leveraged finance conference from March 2–4, 2026. It follows recent events such as the RED-C Phase 3 update on January 23, 2026 and prior participation in the J.P. Morgan Healthcare Conference. Investors may watch for any strategic or financing commentary emerging from the meetings rather than viewing the attendance alone as a fundamental catalyst.

Key Figures

Conference dates: March 2–4, 2026 Announcement date: Feb. 17, 2026

2 metrics

Conference dates March 2–4, 2026 J.P. Morgan Global Leveraged Finance Conference schedule

Announcement date Feb. 17, 2026 Press release date for conference participation

Historical Context

5 past events · Latest: Feb 11 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 11	Scholarship program	Positive	-1.3%	Launch of GI Health Scholars Program with 10 scholarships for students.
Jan 23	Phase 3 update	Negative	-10.1%	RED-C Phase 3 trials safe but failed to meet primary endpoint.
Jan 21	Earnings date set	Neutral	-2.1%	Announcement of Q4 and full-year 2025 results date and call details.
Jan 05	Conference participation	Positive	+2.6%	Participation in 44th J.P. Morgan Healthcare Conference with webcast.
Dec 23	Debt exchange results	Neutral	-1.9%	Final results of exchange offers for 2028 Senior Secured Notes.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news often saw negative or muted price reactions, even to neutral or routine announcements, with only select conference participation news drawing a positive response.

Recent Company History

Over the past few months, Bausch Health news has spanned scholarships, clinical data, conference appearances, and balance sheet actions. A December 23, 2025 update on debt exchange offers and a December 29, 2025 completion notice drew negative to modest reactions. The January 23, 2026 RED-C Phase 3 update, which missed its primary endpoint, coincided with a notably negative move. In contrast, the January 14, 2026 J.P. Morgan Healthcare Conference participation aligned with a positive reaction, similar in nature to today’s conference-focused announcement.

Key Terms

leveraged finance

1 terms

leveraged finance financial

"J.P. Morgan Global Leveraged Finance Conference in Miami Beach, Florida"

Leveraged finance is the use of large amounts of borrowed money, often through high-yield bonds or loans, to fund big moves like buyouts, acquisitions, or major restructuring. It matters to investors because the higher borrowing raises a company’s fixed payments and default risk — similar to a person taking a big mortgage to buy a house — which can amplify both potential returns and losses and influence a firm’s stock and bond safety.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LAVAL, QC, Feb. 17, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that Executive Vice President and CFO Jean-Jacques (JJ) Charhon, along with other management team members, will attend the J.P. Morgan Global Leveraged Finance Conference in Miami Beach, Florida, from March 2–4, 2026, to meet with investors.

About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.

Forward-looking Statements
This news release may contain forward-looking statements within the meaning of applicable securities laws, including the Safe Harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.  Forward-looking statements may generally be identified by the use of the words "will," "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference.  Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events, information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

BHC-FINANCIAL
Investor Contact:	Media Contact:
Garen Sarafian	Katie Savastano
ir@bauschhealth.com	corporate.communications@bauschhealth.com
(877) 281-6642 (toll free)	(908) 569-3692

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-to-participate-in-the-jp-morgan-global-leveraged-finance-conference-302687816.html

SOURCE Bausch Health Companies Inc.

FAQ

Who from Bausch Health (BHC) will attend the J.P. Morgan Global Leveraged Finance Conference on March 2–4, 2026?

Executive Vice President and CFO Jean-Jacques (JJ) Charhon and other management will attend. According to the company, they plan investor meetings in Miami Beach, Florida, across the conference dates to discuss corporate updates and engage with shareholders and fixed-income investors.

What are the dates and location for Bausch Health (BHC) at the J.P. Morgan conference in 2026?

Bausch Health management will be at the conference from March 2–4, 2026, in Miami Beach, Florida. According to the company, the attendance is focused on investor meetings at the J.P. Morgan Global Leveraged Finance Conference during those dates.

Will Bausch Health (BHC) hold investor meetings at the J.P. Morgan Global Leveraged Finance Conference?

Yes. Bausch Health management will meet with investors during the conference. According to the company, the meetings are intended to provide updates and engage with investors, led by CFO Jean-Jacques (JJ) Charhon and other senior team members.

Does Bausch Health (BHC) plan a public presentation at the March 2–4, 2026 J.P. Morgan conference?

The announcement states Bausch Health will attend and meet with investors, not that a public presentation is scheduled. According to the company, participation is described as management meeting investors rather than delivering a formal public talk.

How can investors request meetings with Bausch Health (BHC) at the March 2026 J.P. Morgan conference?

Investors should contact Bausch Health investor relations to request meetings during March 2–4, 2026. According to the company, management plans investor meetings at the Miami Beach conference, so IR is the channel for scheduling and logistics.

What is the investor relevance of Bausch Health (BHC) attending the J.P. Morgan Global Leveraged Finance Conference?

Attendance signals management accessibility to investors and potential dialogue on strategy and financing. According to the company, CFO JJ Charhon and team will meet investors March 2–4, 2026, offering opportunities for questions and direct engagement with leadership.